David Easterhoff

David Easterhoff

Company: Moderna

Job title: Director, Immune Therapeutics Discovery


Exploring the Use of mRNA-LNP for Antigen-Specific Immune Tolerance 9:00 am

Focusing on the mRNA and LNP to identify an optimal drug product for inducing antigen-specific tolerance Highlighting the influence of the antigen on T-cell fate outcomes Interrogating what target product profile may be achievableRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.